ESPCI web site
World Preclinical Congress (WPC)
, 16 December 2017 | Past event
Cyprio’s CEO, Noushin Dianat, presented how our innovative technology has redefined the limits of 3D Cell Culture in the “3D cellular models” session at World Preclinical Congress.
Cyprio’s CEO, Noushin Dianat, presented how our innovative technology has redefined the limits of 3D Cell Culture in the “3D cellular models” session at World Preclinical Congress.
Désolé, les commentaires sont clos pour le moment.